Riskpilot← Back to searchSign inGet full accessCellutions AB
ABActiveOrg 5592759889Erik Dahlbergsgatan 4Beauty care and other beauty treatment activities · NACE 9622Est. 20201-4 employees
Revenue 2025
SEK 2,2M
+98% vs 2024
EBITDA margin
6.8%
+212% vs 2024
Equity ratio
-25.8%
Financial strength
Net profit 2025
SEK 57K
+134% vs 2024
| Revenue | SEK 2,2M | +98% |
| EBITDA | SEK 152K | +212% |
| Net profit | SEK 57K | +134% |
| Total assets | SEK 354K | +27% |
| Equity | SEK -91K | +38% |
| Employees | — | — |
Legal name
Cellutions AB
Org number
5592759889
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
9 oktober 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Cardani, Therese Cristina Larsson, Sofia Åsa Marie
Company purpose
Bolaget skall driva verksamhet inom skönhet med inriktning på bl.a. Laserbehandlingar, hårvård och hudvård.
Address
Erik Dahlbergsgatan 4
Email
info@cellutions.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 394 | 460 | 261 | 1 135 | 2 242 |
| Staff expenses | — | — | — | −414 | −703 |
| EBITDA | −10 | 19 | 18 | −136 | 152 |
| Depreciation & amort. | −0 | — | −8 | −33 | −49 |
| EBIT | −10 | 19 | 9 | −144 | 104 |
| Net financials | −7 | −6 | −13 | −21 | −47 |
| Profit before tax | −17 | 13 | −4 | −166 | 57 |
| Tax | −0 | — | — | — | — |
| Net profit | −17 | 13 | −4 | −166 | 57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 86 | 19 | 17 | 279 | 354 |
| Equity | 8 | 21 | 17 | −148 | −91 |
| Long-term debt | 0 | — | — | 195 | 272 |
| Short-term debt | 77 | −2 | −1 | 233 | 174 |
| Total debt | 77 | −2 | −1 | 428 | 446 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20212025
Equity ratio
-25.8%
This company
38.2%
Market median
-168% vs market
20212025
Return on equity
5709700.0%
This company
18.4%
Market median
+31030878% vs market
20212025
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20212025
Asset turnover
6.33×
This company
1.12×
Market median
+465% vs market
20212025
Debt / equity
4.88×
This company
0.62×
Market median
-687% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Former (4) | ||
| Chairman | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Chairman | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cellutions AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Therese Cristina Cardani | Chairman | 0 companies |
| Anna Emelie Utbult | Chairman | 0 companies |
| Bo Gunnar Markus Utbult | Deputy Board Member | 0 companies |
| Linda Evelina Taube | Chairman | 0 companies |
| Ingrid Christina Taube | Deputy Board Member | 0 companies |
| Sofia Åsa Marie Larsson | Board of Directors | 0 companies |
| Linda Maria Cardani | Deputy Board Member | 0 companies |